MARCUS CORP
For the period ended Dec 28, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control – Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 28, 2023. The Company’s auditors, Deloitte & Touche LLP, have issued an attestation report on our internal control over financial reporting. That attestation report is set forth in this Item 8.
| Gregory S. Marcus | Chad M. Paris |
|---|---|
| President and Chief Executive Officer | Chief Financial Officer and Treasurer |
To the shareholders and the Board of Directors of The Marcus Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of The Marcus Corporation and subsidiaries (the "Company") as of December 28, 2023 and December 29, 2022, the related consolidated statements of earnings (loss), comprehensive income (loss), shareholders' equity and cash flows, for each of the three years in the period ended December 28, 2023, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 28, 2023 and December 29, 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 28, 2023, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 28, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 29, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Long-Lived Assets – Theatres segment property and equipment, net and operating lease right-of-use assets - Assessment and Evaluation of Impairment – Refer to Note 1 and Note 3 to the financial statements
Critical Audit Matter Description
The Company assesses long-lived assets, including property and equipment, net and operating lease right-of-use assets for impairment at the individual theatre or surplus real estate property level whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. During the year ended December 28, 2023, the Company recorded an impairment loss of $1.1 million.
In assessing the Theatres segment property and equipment, net and operating lease right-of-use assets for indicators of potential impairment, the Company considered quantitative and qualitative factors, including evaluating the historical actual operating performance of the properties and assessing the impact of recent economic and industry events impacting the properties. Evaluating whether these quantitative and qualitative factors represented an indicator of potential impairment required significant judgment by management.
When indicators of impairment were present, the Company determined if the individual theatre, or surplus real estate properties were recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets was less than their carrying amounts. In instances where the estimated undiscounted future cash flows attributable to these assets were less than the carrying amounts, the Company determined the fair value of the individual theatre, or surplus real estate properties and recorded an impairment loss based on the excess of the carrying amount over the fair value. The most significant assumption inherent in these recoverability and impairment analyses was the forecasted future cash flows (primarily driven by revenue growth rates for theatre properties and estimated sales prices for surplus real estate properties).
We identified the assessment and evaluation of impairment for the Theatres segment property and equipment, net and operating lease right-of-use assets as a critical audit matter because of the subjectivity used by management when identifying and evaluating potential impairment indicators, and when estimating forecasted future cash flows in their recoverability and impairment analyses. A high degree of auditor judgment was required when performing audit procedures to evaluate whether management appropriately identified and evaluated potential impairment indicators, and when evaluating the reasonableness of management’s forecasted future cash flows that were used in their recoverability and impairment analyses.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s assessment and evaluation of impairment for the Theatres segment property and equipment, net and operating lease right-of-use assets included the following, among others:
We tested the effectiveness of internal controls over the Company’s assessment and evaluation of potential impairment for long-lived assets and over forecasted future cash flows that were used in their recoverability and impairment analyses.
We evaluated the reasonableness of the information in the Company’s impairment indicators analyses, and the corresponding forecasted future cash flows used in their recoverability and impairment analyses, by comparing the forecasts to (1) historical actual information, (2) internal communications between management and the Board of Directors and (3) forecasted information included in analyst and industry reports for the Company.
For surplus real estate properties, we evaluated the reasonableness of the Company’s forecasted cash flows resulting from planned sale of assets by (1) obtaining sales agreements executed after December 28, 2023, where applicable, (2) obtaining negotiated letters of intent to purchase, where applicable, and (3) comparing the Company’s estimates to relevant real estate market data.
We evaluated the Company’s forecasted future cash flows for consistency with evidence obtained in other areas of the audit.
/s/ Deloitte & Touche LLP
Milwaukee, Wisconsin
February 29, 2024
We have served as the Company's auditor since 2008.
To the shareholders and the Board of Directors of The Marcus Corporation
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of The Marcus Corporation and subsidiaries (the “Company”) as of December 28, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 28, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 28, 2023, of the Company and our report dated February 29, 2024, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/Deloitte & Touche LLP
Milwaukee, Wisconsin
February 29, 2024
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents (Note 1) | $55,589 | $21,704 |
| Restricted cash (Note 1) | 4,249 | 2,802 |
| Accounts receivable, net of reserves (Note 5) | 19,703 | 21,455 |
| Assets held for sale (Note 1) | — | 460 |
| Other current assets (Note 1) | 22,175 | 17,474 |
| Total current assets | 101,716 | 63,895 |
| PROPERTY AND EQUIPMENT, NET (Note 5) | 682,262 | 715,765 |
| OPERATING LEASE RIGHT-OF-USE ASSETS (Note 7) | 179,788 | 194,965 |
| OTHER ASSETS: | ||
| Investments in joint ventures (Note 12) | 1,718 | 2,067 |
| Goodwill (Note 1) | 74,996 | 75,015 |
| Other (Note 5) | 24,623 | 12,891 |
| Total other assets | 101,337 | 89,973 |
| Total assets | $1,065,103 | $1,064,598 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $37,384 | $32,187 |
| Taxes other than income taxes | 18,585 | 17,948 |
| Accrued compensation | 22,598 | 22,512 |
| Other accrued liabilities (Note 1) | 57,685 | 56,275 |
| Current portion of finance lease obligations (Note 7) | 2,579 | 2,488 |
| Current portion of operating lease obligations (Note 7) | 15,290 | 14,553 |
| Current maturities of long-term debt (Note 6) | 10,303 | 10,432 |
| Total current liabilities | 164,424 | 156,395 |
| FINANCE LEASE OBLIGATIONS (Note 7) | 12,753 | 15,014 |
| OPERATING LEASE OBLIGATIONS (Note 7) | 178,582 | 195,281 |
| LONG-TERM DEBT (Note 6) | 159,548 | 170,005 |
| DEFERRED INCOME TAXES (Note 10) | 32,235 | 26,567 |
| OTHER LONG- TERM OBLIGATIONS (Note 9) | 46,389 | 44,415 |
| COMMITMENTS AND LICENSE RIGHTS (Note 11) | ||
| EQUITY (NOTE 8): | ||
| Shareholders’ equity attributable to The Marcus Corporation | ||
| Preferred Stock, $1 par; authorized 1,000,000 shares; none issued | — | — |
| Common Stock: | ||
| Common Stock, $1 par; authorized 50,000,000 shares; issued 24,691,548 at December 28, 2023 and 24,498,243 shares at December 29, 2022 | 24,692 | 24,498 |
| Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,078,410 at December 28, 2023 and 7,110,875 at December 29, 2022 | 7,078 | 7,111 |
| Capital in excess of par | 160,642 | 153,794 |
| Retained earnings | 281,599 | 274,254 |
| Accumulated other comprehensive loss | (1,336) | (1,694) |
| 472,675 | 457,963 | |
| Less cost of Common Stock in treasury (47,916 shares at December 28, 2023 and 78,882 shares at December 29, 2022) | (1,503) | (1,866) |
| Total shareholders’ equity attributable to The Marcus Corporation | 471,172 | 456,097 |
| Noncontrolling interests | — | 824 |
| Total equity | 471,172 | 456,921 |
| Total liabilities and shareholders’ equity | $1,065,103 | $1,064,598 |
(in thousands, except per share data)
| Year Ended | |||
|---|---|---|---|
| December 28,2023 | December 29,2022 | December 30,2021 | |
| REVENUES: | |||
| Theatre admissions | $229,186 | $198,485 | $130,740 |
| Rooms | 106,618 | 107,699 | 77,650 |
| Theatre concessions | 197,653 | 180,180 | 118,666 |
| Food and beverage | 73,278 | 74,836 | 47,086 |
| Other revenues | 85,420 | 82,560 | 65,331 |
| 692,155 | 643,760 | 439,473 | |
| Cost reimbursements | 37,420 | 33,634 | 18,771 |
| Total revenues | 729,575 | 677,394 | 458,244 |
| COSTS AND EXPENSES: | |||
| Theatre operations | 230,770 | 212,410 | 140,821 |
| Rooms | 41,071 | 41,561 | 30,394 |
| Theatre concessions | 75,903 | 73,124 | 47,681 |
| Food and beverage | 57,871 | 59,272 | 36,833 |
| Advertising and marketing | 22,838 | 23,877 | 16,069 |
| Administrative | 78,565 | 74,755 | 63,350 |
| Depreciation and amortization | 67,301 | 67,073 | 72,127 |
| Rent (Note 7) | 26,154 | 26,037 | 25,594 |
| Property taxes | 17,871 | 17,955 | 18,473 |
| Other operating expenses (Note 2) | 38,824 | 37,865 | 23,817 |
| Impairment charges (Note 3) | 1,061 | 1,525 | 5,766 |
| Reimbursed costs | 37,420 | 33,634 | 18,771 |
| Total costs and expenses | 695,649 | 669,088 | 499,696 |
| OPERATING INCOME (LOSS) | 33,926 | 8,306 | (41,452) |
| OTHER INCOME (EXPENSE): | |||
| Investment income (loss) | 2,426 | (45) | 599 |
| Interest expense | (12,721) | (15,299) | (18,702) |
| Other income (expense), net | (1,832) | (1,060) | 653 |
| Gain on sale of hotel | — | 6,274 | — |
| Equity losses from unconsolidated joint ventures, net (Note 12) | (149) | (143) | (92) |
| (12,276) | (10,273) | (17,542) | |
| EARNINGS (LOSS) BEFORE INCOME TAXES | 21,650 | (1,967) | (58,994) |
| INCOME TAX EXPENSE (BENEFIT) (Note 10) | 6,856 | 7,137 | (15,701) |
| NET EARNINGS (LOSS) | 14,794 | (9,104) | (43,293) |
| NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS | — | 2,868 | — |
| NET EARNINGS (LOSS) ATTRIBUTABLE TO THE MARCUS CORPORATION | $14,794 | $(11,972) | $(43,293) |
| NET EARNINGS (LOSS) PER SHARE – BASIC: | |||
| Common Stock | $0.48 | $(0.39) | $(1.42) |
| Class B Common Stock | 0.43 | (0.35) | (1.25) |
| NET EARNINGS (LOSS) PER SHARE – DILUTED: | |||
| Common Stock | $0.46 | $(0.39) | $(1.42) |
| Class B Common Stock | 0.43 | (0.35) | (1.25) |
(in thousands)
| Year Ended | |||
|---|---|---|---|
| December 28,2023 | December 29,2022 | December 30,2021 | |
| NET EARNINGS (LOSS) | $14,794 | $(9,104) | $(43,293) |
| OTHER COMPREHENSIVE INCOME (LOSS): | |||
| Pension gain arising during the period, net of tax effect of $171, $2,967 and $687, respectively (Note 9) | 485 | 8,401 | 1,943 |
| Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect (benefit) of $(17), $269 and $342, respectively (Note 9) | (47) | 760 | 969 |
| Fair market value adjustment of interest rate swaps, net of tax effect (benefit) of $(8), $144 and $9, respectively (Note 6) | (22) | 407 | 25 |
| Reclassification adjustment on interest rate swaps included in interest expense, net of tax effect (benefit) of $(20), $64 and $195 respectively (Note 6) | (58) | 182 | 552 |
| Other comprehensive income | 358 | 9,750 | 3,489 |
| COMPREHENSIVE INCOME (LOSS) | 15,152 | 646 | (39,804) |
| COMPREHENSIVE INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS | — | 2,868 | — |
| COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO THE MARCUS CORPORATION | $15,152 | $(2,222) | $(39,804) |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(in thousands, except per share data)
| CommonStock | Class BCommonStock | Capitalin Excessof Par | RetainedEarnings | AccumulatedOtherComprehensiveIncome (Loss) | TreasuryStock | Shareholders'EquityAttributable to The MarcusCorporation | Non-ControllingInterests | TotalEquity | |
|---|---|---|---|---|---|---|---|---|---|
| BALANCES AT DECEMBER 31, 2020 | $23,264 | $7,926 | $153,529 | $331,897 | $(14,933) | $(2,960) | $498,723 | $— | $498,723 |
| Adoption of ASU No. 2020-06 | — | — | (16,511) | 702 | — | — | (15,809) | — | (15,809) |
| Exercise of stock options | — | — | (749) | — | — | 2,279 | 1,530 | — | 1,530 |
| Purchase of treasury stock | — | — | — | — | — | (1,391) | (1,391) | — | (1,391) |
| Savings and profit-sharing contribution | 43 | — | 968 | — | — | — | 1,011 | — | 1,011 |
| Reissuance of treasury stock | — | — | 6 | — | — | 32 | 38 | — | 38 |
| Issuance of non-vested stock | 242 | — | (903) | — | — | 661 | — | — | — |
| Share-based compensation | — | — | 9,316 | — | — | — | 9,316 | — | 9,316 |
| Conversions of Class B Common Stock | 796 | (796) | — | — | — | — | — | — | — |
| Comprehensive income (loss) | — | — | — | (43,293) | 3,489 | — | (39,804) | — | (39,804) |
| BALANCES AT DECEMBER 30, 2021 | 24,345 | 7,130 | 145,656 | 289,306 | (11,444) | (1,379) | 453,614 | — | 453,614 |
| Cash dividends: | |||||||||
| $0.09 per share Class B Common Stock | — | — | — | (640) | — | — | (640) | — | (640) |
| $0.10 per share Common Stock | — | — | — | (2440) | — | — | (2,440) | — | (2,440) |
| Exercise of stock options | — | — | (196) | — | — | 1,089 | 893 | — | 893 |
| Purchase of treasury stock | — | — | — | — | — | (2,286) | (2,286) | — | (2,286) |
| Savings and profit-sharing contribution | 56 | — | 900 | — | — | — | 956 | — | 956 |
| Reissuance of treasury stock | — | — | (5) | — | — | 57 | 52 | — | 52 |
| Issuance of non-vested stock | 78 | — | (731) | — | — | 653 | — | — | — |
| Share-based compensation | — | — | 8,170 | — | — | — | 8,170 | — | 8,170 |
| Conversions of Class B Common Stock | 19 | (19) | — | — | — | — | — | — | — |
| Distribution to noncontrolling interest | — | — | — | — | — | — | — | (2,044) | (2,044) |
| Comprehensive income (loss) | — | — | — | (11,972) | 9,750 | — | (2,222) | 2,868 | 646 |
| BALANCES AT DECEMBER 29, 2022 | 24,498 | 7,111 | 153,794 | 274,254 | (1,694) | (1,866) | 456,097 | 824 | 456,921 |
| Cash dividends: | |||||||||
| $0.22 per share Class B Common Stock | — | — | — | (1,543) | — | — | (1,543) | — | (1,543) |
| $0.24 per share Common Stock | — | — | — | (5,906) | — | — | (5,906) | — | (5,906) |
| Exercise of stock options | — | — | (210) | — | — | 1,295 | 1,085 | — | 1,085 |
| Purchase of treasury stock | — | — | — | — | — | (1,453) | (1,453) | — | (1,453) |
| Savings and profit-sharing contribution | 79 | — | 1,180 | — | — | — | 1,259 | — | 1,259 |
| Reissuance of treasury stock | — | — | (213) | — | — | 300 | 87 | — | 87 |
| Issuance of non-vested stock | 82 | — | (303) | — | — | 221 | — | — | — |
| Share-based compensation | — | — | 6,394 | — | — | — | 6,394 | — | 6,394 |
| Conversions of Class B Common Stock | 33 | (33) | — | — | — | — | — | — | — |
| Distribution to noncontrolling interest | — | — | — | — | — | — | — | (824) | (824) |
| Comprehensive income | — | — | — | 14,794 | 358 | — | 15,152 | — | 15,152 |
| BALANCES AT DECEMBER 28, 2023 | $24,692 | $7,078 | $160,642 | $281,599 | $(1,336) | $(1,503) | $471,172 | $— | $471,172 |
(in thousands)
| Year Ended | |||
|---|---|---|---|
| December 28,2023 | December 29,2022 | December 30,2021 | |
| OPERATING ACTIVITIES | |||
| Net Earnings (loss) | $14,794 | $(9,104) | $(43,293) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||
| Losses on investments in joint ventures | 149 | 143 | 92 |
| Distributions from joint ventures | 200 | 125 | — |
| (Gain) loss on disposition of property, equipment and other assets | 41 | (1,071) | (3,163) |
| Gain on sale of hotel | — | (6,274) | — |
| Impairment charges | 1,061 | 1,525 | 5,766 |
| Depreciation and amortization | 67,301 | 67,073 | 72,127 |
| Amortization of debt issuance costs | 1,467 | 1,614 | 2,198 |
| Share-based compensation | 6,394 | 8,170 | 9,316 |
| Deferred income taxes | 5,561 | 7,033 | (15,843) |
| Other long-term obligations | (95) | (209) | 1,689 |
| Contribution of the Company’s stock to savings and profit-sharing plan | 1,259 | 956 | 1,011 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | 1,893 | 6,838 | (22,055) |
| Government grants receivable | — | 4,335 | 578 |
| Other assets | (2,662) | (1,874) | (2,255) |
| Operating leases | (785) | (1,768) | (5,325) |
| Accounts payable | 4,229 | (3,262) | 21,501 |
| Income taxes | (480) | 22,722 | 8,508 |
| Taxes other than income taxes | 637 | (1,621) | 1,258 |
| Accrued compensation | 63 | 2,038 | 12,841 |
| Other accrued liabilities | 1,602 | (4,180) | 1,300 |
| Total adjustments | 87,835 | 102,313 | 89,544 |
| Net cash provided by operating activities | 102,629 | 93,209 | 46,251 |
| INVESTING ACTIVITIES | |||
| Capital expenditures | (38,774) | (36,843) | (17,082) |
| Proceeds from disposals of property, equipment and other assets | 4,234 | 4,850 | 22,145 |
| Net proceeds from sale of hotel | — | 31,101 | — |
| Capital contribution in joint venture | — | — | (2,427) |
| Proceeds from sale of trading securities | 40 | 141 | 377 |
| Purchase of trading securities | (839) | (263) | (3,080) |
| Property insurance recoveries | — | 1,215 | — |
| Life insurance premium reimbursement | — | — | 11,411 |
| Other investing activities | (1,410) | (547) | (461) |
| Net cash provided by (used in) investing activities | (36,749) | (346) | 10,883 |
| FINANCING ACTIVITIES | |||
| Debt transactions: | |||
| Proceeds from borrowings on revolving credit facility | 38,000 | 100,000 | 178,500 |
| Repayment of borrowings on revolving credit facility | (38,000) | (100,000) | (178,500) |
| Repayment on short-term borrowings | — | (47,499) | (40,346) |
| Principal payments on long-term debt | (11,433) | (35,740) | (10,717) |
| Repayment of borrowing on insurance policy | (6,700) | — | — |
| Proceeds received from borrowing on insurance policy | — | — | 6,700 |
| Principal payments on finance lease obligations | (2,527) | (2,670) | (2,774) |
| Debt issuance costs | (1,334) | (37) | (208) |
| Equity transactions: | |||
| Treasury stock transactions, except for stock options | (503) | (1,467) | (417) |
| Exercise of stock options | 222 | 126 | 594 |
| Dividends paid | (7,449) | (3,080) | — |
| Distributions to noncontrolling interest | (824) | (2,044) | — |
| Net cash used in financing activities | (30,548) | (92,411) | (47,168) |
| Net increase in cash, cash equivalents and restricted cash | 35,332 | 452 | 9,966 |
| Cash, cash equivalents and restricted cash at beginning of year | 24,506 | 24,054 | 14,088 |
| Cash, cash equivalents and restricted cash at end of year | $59,838 | $24,506 | $24,054 |
| Supplemental Information: | |||
| Interest paid, net of amounts capitalized | $9,738 | $13,442 | $14,119 |
| Income taxes refunded (paid), including interest earned | $(1,776) | $21,935 | $8,316 |
| Change in accounts payable for additions to property and equipment | $956 | $(348) | $1,122 |
- Description of Business and Summary of Significant Accounting Policies
Description of Business - The Marcus Corporation and its subsidiaries (the “Company”) operate principally intwo business segments:
Theatres: Operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio, Arkansas, Colorado, Georgia, Kentucky, Louisiana, New York, Pennsylvania, Texas and Virginia and a family entertainment center in Wisconsin.
Hotels and Resorts: Owns and operates full service hotels and resorts in Wisconsin, Illinois and Nebraska and manages full service hotels, resorts and other properties in Wisconsin, Illinois, Minnesota, Iowa, Nevada, Pennsylvania, California and Nebraska.
Principles of Consolidation - The consolidated financial statements include the accounts of The Marcus Corporation and all of its subsidiaries. The Company had ownership interests greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is also included in the accounts of the Company. The Company was the primary beneficiary of the VIE and the Company’s interest was considered a majority voting interest. The primary asset of this VIE, The Skirvin Hilton, was sold on December 16, 2022 as discussed in Note 4 - Asset Sale. The equity interest of outside owners in consolidated entities was recorded as noncontrolling interests in the consolidated balance sheets, and their share of earnings was recorded as net earnings attributable to noncontrolling interests in the consolidated statements of earnings (loss) in accordance with the partnership agreements.
Investments in affiliates which are 50% or less owned by the Company for which the Company exercises significant influence but does not have control are accounted for on the equity method.
All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates - The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Cash Equivalents - The Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
Restricted Cash - Restricted cash consists of bank accounts related to capital expenditure reserve funds, sinking funds, operating reserves and replacement reserves and may include amounts held by a qualified intermediary agent to be used for tax-deferred, like-kind exchange transactions. Restricted cash also includes funds held within the Company's captive insurance entity that are designated to pay expenses related specifically to the captive.
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.
The Company’s assets and liabilities measured at fair value are classified in one of the following categories:
Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At December 28, 2023 and December 29, 2022, respectively, the Company’s $5,364 and $3,932 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At December 28, 2023 and December 29, 2022, the Company had investments in money market funds of $37,018 and $6,000, respectively, that were valued using Level 1 pricing inputs and were included in cash and cash equivalents.
Level 2 - Assets or liabilities for which fair value is based on valuation models for which pricing inputs were either directly or indirectly observable as of the reporting date. At December 29, 2022, the Company’s $108 asset related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs.
Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At December 28, 2023 and December 29, 2022, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets and liabilities that are measured on a non-recurring basis are discussed in Note 3 and Note 6.
The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $70,000 of senior notes, valued using Level 2 pricing inputs, is approximately $64,660 at December 28, 2023, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $100,050 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $148,757 at December 28, 2023, determined based on market rates and the closing trading price of the convertible senior notes as of December 28, 2023 (see Note 6 for further discussion on the Company’s senior notes and convertible senior notes). The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.
Accounts Receivable - The Company evaluates the collectability of its accounts receivable based on a number of factors. For larger accounts, an allowance for doubtful accounts is recorded based on the applicable parties’ ability and likelihood to pay based on management’s review of the facts. For all other accounts, the Company recognizes an allowance based on length of time the receivable is past due based on historical experience and industry practice.
Inventory - Inventories, consisting of food and beverage and concession items, are stated at the lower of cost or market. Cost has been determined using the first-in, first-out method. Inventories of $5,914 and $5,662 as of December 28, 2023 and December 29, 2022, respectively, were included in other current assets.
Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of December 29, 2022, assets held for sale consisted primarily of land.
Property and Equipment - The Company records property and equipment at cost. Major renewals and improvements are capitalized, while maintenance and repairs that do not improve or extend the lives of the respective assets are expensed currently. Included in property and equipment are assets related to finance leases. These assets are depreciated over the shorter of the estimated useful lives or related lease terms.
Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the following estimated useful lives or any related lease terms:
| Years | |
|---|---|
| Land improvements | 10 - 20 |
| Buildings and improvements | 12 - 39 |
| Leasehold improvements | 3 - 40 |
| Furniture, fixtures and equipment | 2 - 20 |
| Finance lease right-of-use assets | 4 - 15 |
Depreciation expense totaled $67,269, $67,041 and $72,044 for fiscal 2023, fiscal 2022 and fiscal 2021, respectively.
Long-Lived Assets - The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. During fiscal 2023 and fiscal 2022, the Company determined that indicators of impairment were present. As such, the Company evaluated the value of its property and equipment and the value of its operating lease right-of-use assets and recorded impairment charges in as discussed in Note 3.
Acquisition - The Company recognizes identifiable assets acquired, liabilities assumed and noncontrolling interests assumed in an acquisition at their fair values at the acquisition date based upon all information available to it, including third-party appraisals. Acquisition-related costs, such as due diligence and legal fees, are expensed as incurred. The excess of the acquisition cost over the fair value of the identifiable net assets is reported as goodwill.
Goodwill - The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. Goodwill is tested for impairment at a reporting unit level, determined to be at an operating segment level. When reviewing goodwill for impairment, the Company considers the amount of excess fair value over the carrying value of the reporting unit, the period of time since its last quantitative test, and other factors to determine whether or not to first perform a qualitative test. When performing a qualitative test, the Company assesses numerous factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying value. Examples of qualitative factors that the Company assesses include its share price, its financial performance, market and competitive factors in its industry, and other events specific to the reporting unit. If the Company concludes that it is more likely than not that the fair value of its reporting unit is less than it carrying value, the Company performs a quantitative impairment test by comparing the carrying value of the reporting unit to the estimated fair value.
During fiscal 2023 and fiscal 2022, the Company performed a quantitative analysis for its annual goodwill impairment test as of September 29, 2023 and September 30, 2022, respectively. In order to determine fair value, the Company used assumptions based on information available to it as the date of the quantitative test, including both market data and forecasted cash flows (Level 3 pricing inputs). The Company determined that the fair value of its goodwill was greater than its carrying value and deemed thatno impairment was indicated in either fiscal 2023 or fiscal 2022.
At December 28, 2023 and December 29, 2022, the Company’s goodwill balance was $74,996 and $75,015, respectively. The change in goodwill is due to a deferred tax adjustment related to the prior acquisition of a business. Substantially all of the Company’s goodwill relates to the theatre reporting unit.
Trade Name Intangible Asset – The Company recorded a trade name intangible asset in conjunction with the Movie Tavern acquisition that was determined to have an indefinite life. The Company reviews its trade name intangible asset for impairment at least annually or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable.
Capitalization of Interest - The Company capitalizes interest during construction periods by adding such interest to the cost of constructed assets. Interest of approximately $43, $18 and $23 was capitalized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.
Debt Issuance Costs - The Company records debt issuance costs on short-term borrowings and long-term debt as a direct deduction from the related debt liability. Debt issuance costs related to the Company’s revolving credit facility are included in other long-term assets. Debt issuance costs are deferred and amortized over the term of the related debt agreements. Amortization of debt issuance costs totaled $1,467, $1,614 and $2,198 for fiscal 2023, fiscal 2022 and fiscal 2021, respectively, and were included in interest expense on the consolidated statements of earnings (loss).
Leases - The Company follows Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2016-02, Leases, (Accounting Standards Codification (ASC) 842), when accounting for leases. See Note 7 - Leases.
Investments – The Company has investments in debt and equity securities. These securities are stated at fair value based on listed market prices, where available, with the change in fair value recorded as investment income or loss within the consolidated statements of earnings (loss). The cost of securities sold is based upon the specific identification method.
Revenue Recognition - The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. See Note 2 - Revenue Recognition.
Advertising and Marketing Costs - The Company expenses all advertising and marketing costs as incurred.
Insurance Reserves - The Company uses a combination of insurance and self insurance mechanisms, including participation in captive insurance entities, to provide for the potential liabilities for certain risks, including workers’ compensation, healthcare benefits, general liability, property insurance, director and officers’ liability insurance, cyber liability, employment practices liability and business interruption. Liabilities associated with the risks that are retained by the company are not discounted and are estimated, in part, by considering historical claims experience, demographic factors and severity factors.
Income Taxes -The Company recognizes deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities. Deferred tax assets represent items to be used as a tax deduction or credit in the future tax returns for which the Company has already properly recorded the tax benefit in the income statement. The Company regularly assesses the probability that the deferred tax asset balance will be recovered against future taxable income, taking into account such factors as earnings history, carryback and carryforward periods, and tax strategies. When the indications are that recovery is not probable, a valuation allowance is established against the deferred tax asset, increasing income tax expense in the year that conclusion is made.
The Company assesses income tax positions and records tax benefits for all years subject to examination based upon management’s evaluation of the facts, circumstances and information available at the reporting dates. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, the Company records the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit is recognized in the financial statements. See Note 10 - Income Taxes.
Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.
Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.
The following table illustrates the computation of Common Stock and Class B Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:
| Year Ended | |||
|---|---|---|---|
| December 28,2023 | December 29,2022 | December 30,2021 | |
| Numerator: | |||
| Net earnings (loss) attributable to The Marcus Corporation | $14,794 | $(11,972) | $(43,293) |
| Denominator (in thousands): | |||
| Denominator for basic EPS | 31,658 | 31,488 | 31,360 |
| Effect of dilutive employee stock options | 44 | — | — |
| Effect of convertible notes | 9,287 | — | — |
| Denominator for diluted EPS | 40,989 | 31,488 | 31,360 |
| Net earnings (loss) per share – Basic: | |||
| Common Stock | $0.48 | $(0.39) | $(1.42) |
| Class B Common Stock | $0.43 | $(0.35) | $(1.25) |
| Net earnings (loss) per share- Diluted: | |||
| Common Stock | $0.46 | $(0.39) | $(1.42) |
| Class B Common Stock | $0.43 | $(0.35) | $(1.25) |
For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect.
At December 29, 2022 and December 30, 2021, respectively, approximately 75,000 and 104,000 common stock equivalents were excluded from the computation of diluted net loss per share because of the Company’s net loss. At December 29, 2022 and December 30, 2021, approximately 9,141,140 and 9,084,924 common stock equivalents underlying the conversion of the convertible senior notes were excluded from the computation of diluted net loss per share because of the Company’s net loss. Additionally, options to purchase 2,933,000 shares,2,547,000 shares and 1,999,000 shares of common stock at prices ranging from $15.99 to $41.90, $16.32 to $41.90 and $18.68 to $41.90 per share were outstanding at December 28, 2023, December 29, 2022 and December 30, 2021, respectively, but were not included in the computation of diluted EPS because the options’ exercise price was greater than the average market price of the common shares, and therefore, the effect would be antidilutive.
Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Unrecognized gain on interest rate swap agreements | $— | 80 |
| Net unrecognized actuarial loss for pension obligation | (1,336) | (1,774) |
| $(1,336) | $(1,694) |
New Accounting Pronouncements - During the first quarter of fiscal 2022, the Company adopted Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendments in this update provide increased transparency of government assistance including the requirement of certain disclosures in a company’s notes to the consolidated financial statements about transactions with a government. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.
In March 2020, the Financial Accounting Standards Board (FASB) issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (LIBOR), or other interbank offered rates, to alternative reference rates such as the Secured Overnight Financing Rate (SOFR). During the first quarter of fiscal 2023, in conjunction with the execution of the fifth amendment to the Company’s credit agreement (see Note 6), the Company elected SOFR as its ongoing reference rate. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280: Improvements to Reportable Segment Disclosures (ASU No. 2023-07), which requires disclosure of incremental segment information on an annual and interim basis. ASU No 2023-07 will be effective for the Company’s fiscal year ending December 26, 2024, and the Company’s interim periods beginning in fiscal 2025. The Company is evaluating the effect that the guidance will have on its consolidated financial statement disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740: Improvements to Income Tax Disclosures (ASU No. 2023-09), which requires improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid information. ASU No. 2023-09 will be effective for the Company in fiscal 2025 and must be applied prospectively with retrospective application permitted. The Company is evaluating the impact that ASU No. 2023-09 will have on its consolidated financial statement disclosures.
- Revenue Recognition
Revenue from contracts with customers is recognized when, or as, the Company satisfies its performance of obligations by transferring the promised services to the customer. A service is transferred to a customer when, or as, the customer obtains control of that service. A performance obligation may be satisfied over time or at a point in time. Revenue from a performance obligation satisfied over time is recognized by measuring the Company’s progress in satisfying the performance obligation in a manner that depicts the transfer of the services to the customer. Revenue from a performance obligation satisfied at a point in time is recognized at the point in time that the Company determines the customer obtains
- Revenue Recognition (continued)
control over the promised service. The amount of revenue recognized reflects the consideration entitled to in exchange for those services.
The disaggregation of revenues by business segment for fiscal 2023, fiscal 2022 and fiscal 2021 is as follows:
| Fiscal 2023 | ||||
|---|---|---|---|---|
| Reportable Segment | ||||
| Theatres | Hotels/Resorts | Corporate | Total | |
| Theatre admissions | $229,186 | $— | $— | $229,186 |
| Rooms | — | 106,618 | — | 106,618 |
| Theatre concessions | 197,653 | — | — | 197,653 |
| Food and beverage | — | 73,278 | — | 73,278 |
| Other revenues(1) | 31,555 | 53,519 | 346 | 85,420 |
| Cost reimbursements | — | 37,420 | — | 37,420 |
| Total revenues | $458,394 | $270,835 | $346 | $729,575 |
| Fiscal 2022 | ||||
|---|---|---|---|---|
| Reportable Segment | ||||
| Theatres | Hotels/Resorts | Corporate | Total | |
| Theatre admissions | $198,485 | $— | $— | $198,485 |
| Rooms | — | 107,699 | — | 107,699 |
| Theatre concessions | 180,180 | — | — | 180,180 |
| Food and beverage | — | 74,836 | — | 74,836 |
| Other revenues(1) | 29,076 | 53,117 | 367 | 82,560 |
| Cost reimbursements | — | 33,634 | — | 33,634 |
| Total revenues | $407,741 | $269,286 | $367 | $677,394 |
| Fiscal 2021 | ||||
|---|---|---|---|---|
| Reportable Segment | ||||
| Theatres | Hotels/Resorts | Corporate | Total | |
| Theatre admissions | $130,740 | $— | $— | $130,740 |
| Rooms | — | 77,650 | — | 77,650 |
| Theatre concessions | 118,666 | — | — | 118,666 |
| Food and beverage | — | 47,086 | — | 47,086 |
| Other revenues(1) | 21,754 | 43,219 | 358 | 65,331 |
| Cost reimbursements | 88 | 18,683 | — | 18,771 |
| Total revenues | $271,248 | $186,638 | $358 | $458,244 |
(1)Included in other revenues is an immaterial amount related to rental income that is not considered contract revenue from contracts with customers under ASC 606.
The Company recognizes revenue from its rooms as earned on the close of business each day. Revenue from theatre admissions, theatre concessions and food and beverage sales are recognized at the time of sale.
Revenues from advanced ticket and gift card sales are recorded as deferred revenue and are recognized when tickets or gift cards are redeemed. Gift card breakage income is recognized based upon historical redemption patterns and represents the balance of gift cards for which the Company believes the likelihood of redemption by the customer is remote. Gift card breakage income is recorded in other revenues in the consolidated statements of earnings (loss).
- Revenue Recognition (continued)
Other revenues include management fees for theatres and hotels under management agreements. The management fees are recognized as earned based on the terms of the agreements. The management fees include variable consideration that is recognized based on the Company’s right to invoice as the amount invoiced corresponds directly to the value transferred to the customer. Other revenues also include family entertainment center revenues and revenues from Hotels/Resorts outlets such as spa, ski, golf and parking, each of which are recognized at the time of sale. In addition, other revenues include pre-show advertising income in the Company’s theatres. Pre-show advertising revenue includes variable consideration, primarily based on attendance levels, that is allocated to distinct time periods that make up the overall performance obligation.
Cost reimbursements primarily consist of payroll and related expenses at managed properties where the Company is the employer and may include certain operational and administrative costs as provided for in the Company’s contracts with owners. These costs are reimbursed back to the Company. As these costs have no added markup, the revenue and related expense have no impact on operating income (loss) or net earnings (loss).
The timing of the Company’s revenue recognition may differ from the timing of payment by customers. However, the Company typically receives payment within a very short period of time of when the revenue is recognized. The Company records a receivable when revenue is recognized prior to payment and it has an unconditional right to payment. Alternatively, when payment precedes the provision for the related services, deferred revenue is recorded until the performance obligation is satisfied.
Revenues do not include sales tax as the Company considers itself a pass-through conduit for collecting and remitting sales tax.
The Company had deferred revenue from contracts with customers of $38,034, $37,046 and $39,144 as of December 28, 2023, December 29, 2022 and December 30, 2021, respectively. The Company hadno contract assets as of December 28, 2023 and December 29, 2022. During fiscal 2023, the Company recognized revenue of $18,587 that was included in deferred revenues as of December 29, 2022. During fiscal 2022, the Company recognized revenue of $15,863 that was included in deferred revenues as of December 30, 2021. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.
As of December 28, 2023, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $2,052 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of December 28, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $17,828 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the nexttwo years.
As of December 28, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,601 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the nexttwo years.
The majority of the Company’s revenue is recognized in less than one year from the original contract.
- Impairment Charges
During fiscal 2023, fiscal 2022 and fiscal 2021, the Company determined that indicators of impairment were present at certain theatre asset groups. For certain of the theatre asset groups evaluated for impairment, the sum of the estimated undiscounted future cash flows attributable to certain theatre assets was less than their carrying amounts. The Company evaluated the fair value of these assets, consisting primarily of land, building and furniture, fixtures and equipment, and operating lease right-of-use assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary assets, including estimated sale proceeds) was less than their carrying value and recorded impairment losses of $1,061, $1,525 and $5,766 in fiscal 2023, fiscal 2022 and fiscal 2021, respectively, reducing certain property and equipment and certain operating lease right-of-use assets. The
- Impairment Charges (continued)
remaining net book value of the impaired assets was $6,429 as of December 28, 2023, $5,229 as of December 29, 2022, and $11,689 as of December 30, 2021, excluding any applicable remaining lease obligations.
- Asset Sale
On December 16, 2022, the Company, together with its noncontrolling interest joint venture partner, Skirvin Partners in Development, sold The Skirvin Hilton hotel in Oklahoma City, Oklahoma for a total sale price of $36,750. The assets sold consisted primarily of land, building, equipment and other assets. Net proceeds from the sale were approximately $31,101, net of transaction costs of $609 and retirement of a ground lease obligation of $5,040. The retirement of the ground lease obligation resulted in the Company owning the land, which was then conveyed to the buyer. Additionally, $24,111 in mortgage debt was retired. The transaction resulted in a gain on sale of $6,274. The Skirvin Hilton revenues for fiscal 2022 through the date of sale and fiscal 2021 were $15,979, and $12,121, respectively. The Skirvin Hilton operating loss was $387 and $104 for fiscal 2022 and fiscal 2021, respectively. Pursuant to the terms of the partnership agreement, $824 and $2,044 was distributed to noncontrolling interests during fiscal 2023 and fiscal 2022, respectively, representing the partner’s share of net sales proceeds and partnership liquidation proceeds.
- Additional Balance Sheet Information
The composition of accounts receivable is as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Trade receivables, net of allowances of $115 and $172, respectively | $7,636 | $6,707 |
| Other receivables | 12,067 | 14,748 |
| $19,703 | $21,455 |
The composition of property and equipment, which is stated at cost, is as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Land and improvements | $131,833 | $132,285 |
| Buildings and improvements | 719,521 | 729,177 |
| Leasehold improvements | 166,245 | 167,516 |
| Furniture, fixtures and equipment | 397,150 | 386,197 |
| Finance lease right-of-use assets | 30,106 | 29,885 |
| Construction in progress | 11,432 | 10,305 |
| 1,456,287 | 1,455,365 | |
| Less accumulated depreciation and amortization | 774,025 | 739,600 |
| $682,262 | $715,765 |
The composition of other assets is as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Intangible assets | $6,904 | $6,945 |
| Cash surrender value of insurance policy | 8,276 | 1,033 |
| Other assets | 9,443 | 4,913 |
| $24,623 | $12,891 |
- Additional Balance Sheet Information (continued)
Included in intangible assets is a trade name valued at $6,900 as of December 28, 2023 and December 29, 2022 that has an indefinite life. The balance in cash surrender value of insurance policy as of December 29, 2022 included a $6,700 loan that net against the value of the policy. The loan was repaid during fiscal 2023.
- Long-Term Debt
Long-term debt is summarized as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Senior notes | $70,000 | $80,000 |
| Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75% | 528 | 954 |
| Convertible senior notes | 100,050 | 100,050 |
| Payroll Protection Program loans | 1,233 | 2,240 |
| Revolving credit agreement | — | — |
| Debt issuance costs | (1,960) | (2,807) |
| Total debt, net of debt issuance costs | 169,851 | 180,437 |
| Less current maturities, net of issuance costs | 10,303 | 10,432 |
| Long-term debt | $159,548 | $170,005 |
Credit Agreement
On January 9, 2020, the Company replaced its then-existing credit agreement with several banks. On April 29, 2020, the Company entered into the First Amendment, on September 15, 2020, the Company entered into the Second Amendment, on July 13, 2021, the Company entered into the Third Amendment, on July 29, 2022, the Company entered into the Fourth Amendment, on February 10, 2023, the Company entered into the Fifth Amendment and on October 16, 2023, the Company entered into the Sixth Amendment (the Credit Agreement, as amended by the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment and the Sixth Amendment, hereinafter referred to as the “Credit Agreement”).
The Credit Agreement provides for a newfive-year revolving credit facility that matures on October 16, 2028 with an initial maximum aggregate amount of availability of $225,000. At December 28, 2023, there wereno borrowings outstanding on the revolving credit facility, which when borrowed, bear interest at SOFR plus a margin (as discussed further below), effectively 7.28% at December 28, 2023. Availability under the $225,000 revolving credit facility was $220,623 as of December 28, 2023 after taking into consideration outstanding letters of credit that reduce revolver availability.
Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) the term secured overnight financing rate (“SOFR”), plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon our net leverage ratio as of the most recent determination date, or (ii) the alternate base rate (“ABR”) (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon our net leverage ratio as of the most recent determination date; provided, however, as of the effective date of the Sixth Amendment, in respect of revolving loans, the applicable margin is 1.75% for SOFR borrowings and 0.75% for ABR borrowings, and will be adjusted for the first time thereafter based upon our net leverage ratio as determined for the fiscal year ending December 28, 2023. The revolving credit facility also requires an annual facility fee equal to 0.175% to 0.275% of the total revolving commitments depending on our consolidated net leverage ratio; provided, however that such fee will be 0.25% and will be adjusted for the first time thereafter based upon our consolidated net leverage ratio as determined for the fiscal year ending December 28, 2023.
The Credit Agreement includes, among other restrictions and covenants applicable to the Company, a requirement that our consolidated net leverage ratio not exceed 3.50:1.00, provided that, with some limitations, such ratio may be increased to 4.00:1:00 for the full fiscal quarter in which a material acquisition (in which aggregate consideration equals or exceeds $30,000) is consummated and the three fiscal quarters immediately thereafter, and a requirement that our interest coverage ratio at the end of any fiscal quarter not be less than 3.00:1.00.
In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement.
The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.
Note Purchase Agreements
The Company’s $70,000 of senior notes consist oftwo Note Purchase Agreements maturing in 2025 through 2027, require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 4.32%, with a weighted-average fixed rate of 4.23% at December 28, 2023 and 4.21% at December 29, 2022.
On October 16, 2023, the Company and certain purchasers entered into amendments (the “Note Amendments”) to the Note Purchase Agreement, dated June 27, 2013, and the Note Purchase Agreement, dated December 21, 2016 (collectively, the “Note Purchase Agreements”). The Note Amendments amend certain covenants and other terms of the Note Purchase Agreements and are consistent with the amended covenants and collateral provisions that are referenced in the Credit Agreement section above.
In connection with the Note Amendments: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of their respective personal property assets and (b) certain of their respective real property assets, in each case, to secure the Notes and related obligations; and (ii) certain subsidiaries of the Company have guaranteed the Company's obligations under the Note Purchase Agreements and the Notes.
The Note Purchase Agreements contain customary events of default. If an event of default under the Note Purchase Agreements occurs and is continuing, then, among other things, all Notes then outstanding become immediately due and payable and the Note holders may exercise their rights and remedies against the pledged collateral.
Convertible Senior Notes
On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee. The net proceeds from the sale of the Convertible Notes were approximately $95,421 after deducting the Initial Purchasers’ fees and additional fees and expenses related to the offering. The Company used $16,908 of net proceeds from the offering to pay the cost of the Capped Call Transactions (as described below). The remainder of the net proceeds were used to repay borrowings under the Company’s revolving credit facility and for general corporate purposes. The Convertible Notes are senior unsecured obligations and rank (i) senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the Convertible Notes; (ii) equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated; (iii) effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and (iv) structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries.
The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 30, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.
Upon conversion, the Convertible Notes may be settled, at the company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate was 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. The conversion rate is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At December 28, 2023, the adjusted conversion rate is 92.82 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an adjusted conversion price of approximately $10.77 per share of Common Stock). If the Company undergoes certain fundamental changes, holders of Convertible Notes may require the Company to repurchase for cash all or part of their Convertible Notes for a purchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a make-whole fundamental change occurs prior to the maturity date, the Company will, under certain circumstances, increase the conversion rate for holders who convert Convertible Notes in connection with such make-whole fundamental change. The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes. The Indenture includes covenants customary for securities similar to the Convertible Notes, sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company and certain of its subsidiaries after which the Convertible Notes become automatically due and payable.
Since the Company’s fiscal 2021 second quarter, the Company’s Convertible Notes have been eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. As such, the Convertible Notes will continue to be classified as long-term. Future convertibility and resulting balance sheet classification of this liability will be monitored at each quarterly reporting date and will be analyzed dependent upon market prices of the Company’s Common Stock during the prescribed measurement period. No Convertible Notes have been converted to date and the Company does not expect any to be converted within the next 12 months.
Capped Call Transactions
In connection with the pricing of the Convertible Notes on September 17, 2020, and in connection with the exercise by the Initial Purchasers of their option to purchase additional Convertible Notes on September 18, 2020, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain of the Initial Purchasers and/or their respective affiliates and/or other financial institutions (the “Capped Call Counterparties”). The Capped Call Transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of the Convertible Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of such converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti- dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the Capped Call Transactions. The cap price of the Capped Call Transactions was initially $17.98 per share (in no event shall the cap price be less than the strike price of $11.0128), which represents a premium of 100% over the last reported sale price of the Common Stock of $8.99 per share on The New York Stock Exchange on September 17, 2020. Under the terms of the Capped Call Transactions, the cap price is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At December 28, 2023, the adjusted cap price is approximately $17.59 per share. The Capped Call Transactions are separate transactions entered into by the Company with the Capped Call Counterparties, are not part of the terms of the Convertible Notes and will not change the rights of holders of the Convertible Notes under the Convertible Notes and the Indenture.
Paycheck Protection Program Loans
During fiscal 2020,11 of the Company’s subsidiaries received proceeds totaling $13,459 under the CARES Act’s Paycheck Protection Program (PPP). The PPP loans bear interest at a fixed interest rate of 1.0%, require principal and interest payments that began in April 2021, and mature in fiscal 2026. The Company’s subsidiaries used a cumulative total of approximately $10,012 of the PPP loan proceeds to pay for qualified expenses, which were forgiven under the terms of the CARES Act program during fiscal 2021.
Scheduled annual principal payments on long-term debt, net of amortization of debt issuance costs, for the years subsequent to December 28, 2023, are as follows:
| Fiscal Year | |
|---|---|
| 2024 | $10,303 |
| 2025 | 109,631 |
| 2026 | — |
| 2027 | 49,917 |
| 2028 | — |
| Thereafter | — |
| $169,851 | |
Derivatives
The Company utilizes derivatives principally to manage market risks and reduce its exposure resulting from fluctuations in interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions. The Company recognizes derivatives as either assets or liabilities on the consolidated balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and on the type of hedging relationship. Derivatives that do not qualify for hedge accounting must be adjusted to fair value through earnings. For derivatives that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The Company’s interest rate swap agreements were considered effective and qualified as cash flow hedges. The Company assesses, both at the inception of each hedge and on an on-going basis, whether the derivatives that are used in its hedging transactions are highly effective in offsetting changes in cash flows of the hedged items.
The Company entered intotwo interest rate swap agreements on March 1, 2018 covering $50,000 of LIBOR floating rate debt. The first agreement had a notional amount of $25,000, expired March 1, 2021, and required the Company to pay interest at a defined rate of 2.559% while receiving interest at a defined variable rate of one-month LIBOR. The second agreement had a notional amount of $25,000, expired March 1, 2023, and required the Company to pay interest at a defined rate of 2.687% while receiving interest at a defined variable rate of one-month LIBOR. The fair value of the interest rate swap on December 29, 2022, was an asset of $108, which was included in other current assets in the consolidated balance sheet. There were no interest rate swaps outstanding at December 28, 2023.
- Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to accounting guidance ASC 842. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms ofone year to 45 years, some of which include options to extend and/or terminate the lease. The exercise of lease renewal options is done at the Company’s sole discretion. When deemed reasonably certain of exercise, the renewal options are included in the determination of the lease term and related right-of-use asset and lease liability. The depreciable life of the asset is limited to the expected term. The Company’s lease agreements do not contain any residual value guarantees or any restrictions or covenants.
Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When readily determinable, the Company uses the implicit rate in the lease in determining the present value of lease payments. When the lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date, including the fixed rate the Company could borrow for a similar amount, over a similar lease term with similar collateral. The Company recognizes right-of-use assets for all assets subject to operating leases in an amount equal to the operating lease liabilities, adjusted for the balances of long-term prepaid rent, favorable lease intangible assets, deferred lease expense, unfavorable lease liabilities and deferred lease incentive liabilities. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
Total lease cost consists of the following:
| Lease Cost | Classification | Fiscal 2023 | Fiscal 2022 |
|---|---|---|---|
| Finance lease costs: | |||
| Amortization of finance lease assets | Depreciation and amortization | $2,760 | $2,789 |
| Interest on lease liabilities | Interest expense | 759 | 850 |
| $3,519 | $3,639 | ||
| Operating lease costs: | |||
| Operating lease costs | Rent expense | $24,126 | $25,381 |
| Variable lease cost | Rent expense | 1,892 | 514 |
| Short-term lease cost | Rent expense | 136 | 142 |
| $26,154 | $26,037 | ||
- Leases (continued)
Additional information related to leases is as follows:
| Other Information | Fiscal 2023 | Fiscal 2022 |
|---|---|---|
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Financing cash flows from finance leases | $2,527 | $2,670 |
| Operating cash flows from finance leases | 759 | 850 |
| Operating cash flows from operating leases | 25,391 | 29,025 |
| Right of use assets obtained in exchange for new lease obligations: | ||
| Finance lease liabilities | 357 | 419 |
| Operating lease liabilities, including from acquisitions | 276 | 275 |
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Finance leases: | ||
| Property and equipment – gross | $30,106 | $29,885 |
| Accumulated depreciation and amortization | (17,956) | (15,332) |
| Property and equipment - net | $12,150 | $14,553 |
Remaining lease terms and discount rates are as follows:
| Lease Term and Discount Rate | December 28, 2023 | December 29, 2022 |
|---|---|---|
| Weighted-average remaining lease terms: | ||
| Finance leases | 7 years | 7 years |
| Operating leases | 12 years | 12 years |
| Weighted-average discount rates: | ||
| Finance leases | 4.62% | 4.59% |
| Operating leases | 4.52% | 4.51% |
Maturities of lease liabilities as of December 28, 2023 are as follows:
| Fiscal Year · Operating Leases · Finance Leases | |||
|---|---|---|---|
| 2024 | $23,649 | $3,236 | |
| 2025 | 25,232 | 3,080 | |
| 2026 | 24,798 | 2,965 | |
| 2027 | 23,181 | 1,991 | |
| 2028 | 22,295 | 1,892 | |
| Thereafter | 132,386 | 4,734 | |
| Total lease payments | 251,541 | 17,898 | |
| Less: amount representing interest | (57,669) | (2,566) | |
| Total lease liabilities | $193,872 | $15,332 | |
Deferred rent payments of approximately $859 for the Company’s operating leases have been included in the total operating lease obligations as of December 28, 2023, of which approximately $476 is included in long-term operating lease obligations.
- Shareholders’ Equity and Share-Based Compensation
Shareholders may convert their shares of Class B Common Stock into shares of Common Stock at any time. Class B Common Stock shareholders are substantially restricted in their ability to transfer their Class B Common Stock. Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of the Class B Common Stock. Holders of Class B Common Stock are entitled toten votes per share while holders of Common Stock are entitled toone vote per share on any matters brought before the shareholders of the Company. Liquidation rights are the same for both classes of stock.
Through December 28, 2023, the Company’s Board of Directors has approved the repurchase of up to 11,687,500 shares of Common Stock to be held in treasury. The Company intends to reissue these shares upon the exercise of stock options and for savings and profit-sharing plan contributions. The Company repurchased 94,508,134,694 and 61,654 shares pursuant to these authorizations during fiscal 2023, fiscal 2022 and fiscal 2021, respectively. At December 28, 2023, there were 2,428,138 shares available for repurchase under these authorizations.
The Company’s Board of Directors has authorized the issuance of up to 750,000 shares of Common Stock for The Marcus Corporation Dividend Reinvestment and Associate Stock Purchase Plan. At December 28, 2023, there were 412,815 shares available under this authorization.
Shareholders have approved the issuance of up to 7,437,500 shares of Common Stock under various equity incentive plans. Stock options granted under the plans to employees generally become exercisable either 40% after two years,60% after three years,80% after four years and 100% after five years of the date of grant, or 50% after two years,75% after three years and 100% after four years of the date of grant, depending on the date of grant. The options generally expire ten years from the date of grant as long as the optionee is still employed with the Company.
Awarded shares of non-vested stock cumulatively vest either 25% after three years of the grant date,50% after five years of the grant date,75% after ten years of the grant date and 100% upon retirement, or 50% after three years of the grant date and 100% after five years of the grant date, or 50% after two years of the grant date and 100% after four years of the grant date, depending on the date of grant, or in the case of a special grant awarded in fiscal 2021, one year after the date of grant. The non-vested stock may not be sold, transferred, pledged or assigned, except as provided by the vesting schedule included in the Company’s equity incentive plan. During the period of restriction, the holder of the non-vested stock has voting rights and is entitled to receive all dividends and other distributions paid with respect to the stock. Non-vested stock awards and shares issued upon option exercises may be issued from previously acquired treasury shares. At December 28, 2023, there were 1,085,339 shares available for grants of additional stock options, non-vested stock and other types of equity awards under the current plan.
Share-based compensation, including stock options and non-vested stock awards, is expensed over the vesting period of the awards based on the grant date fair value.
The Company estimated the fair value of stock options using the Black-Scholes option pricing model with the following assumptions used for awards granted during fiscal 2023, fiscal 2022 and fiscal 2021:
| Year Ended | |||
|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | |
| Risk-free interest rate | 3.83 – 4.24% | 1.73 – 3.90% | 0.97 – 1.26% |
| Dividend yield | 1.50 - 1.80% | 1.50% | 1.50% |
| Volatility | 49 - 54% | 48 – 53% | 28 – 53% |
| Expected life | 6 – 8 years | 6 – 8 years | 6 – 8 years |
- Shareholders’ Equity and Share-Based Compensation (continued)
Total pre-tax share-based compensation expense was $6,394, $8,170 and $9,316 in fiscal 2023, fiscal 2022 and fiscal 2021, respectively. The recognized tax benefit on share-based compensation was $1,000, $1,338 and $1,997 in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.
A summary of the Company’s stock option activity and related information follows (shares in thousands):
| Year Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| December 28, 2023 · December 29, 2022 · December 30, 2021 | ||||||||
| Options · Weighted-AverageExercisePrice · Options · Weighted-AverageExercisePrice · Options · Weighted-AverageExercisePrice | ||||||||
| Outstanding at beginning of period | 2,866 | $23.76 | 2,533 | $24.84 | 2,234 | $24.87 | ||
| Granted | 525 | 15.96 | 501 | 16.99 | 531 | 21.74 | ||
| Exercised | (83) | 13.05 | (68) | 13.15 | (134) | 11.42 | ||
| Forfeited | (135) | 25.11 | (100) | 24.89 | (98) | 26.60 | ||
| Outstanding at end of period | 3,173 | 22.69 | 2,866 | 23.76 | 2,533 | 24.84 | ||
| Exercisable at end of period | 1,989 | $25.53 | 1,613 | $25.70 | 1,119 | $24.76 | ||
| Weighted-average fair value of options granted during the period | $7.86 | $7.71 | $9.47 | |||||
Exercise prices for options outstanding as of December 28, 2023 ranged from $12.71 to $41.90. The weighted-average remaining contractual life of those options is 6.1 years. The weighted-average remaining contractual life of options currently exercisable is 4.8 years. There were 3,135,000 options outstanding, vested and expected to vest as of December 28, 2023, with a weighted-average exercise price of $22.76 and an intrinsic value of $435. Additional information as of December 28, 2023 related to options outstanding segregated by exercise price range is as follows (shares in thousands):
| Exercise Price Range | |||
|---|---|---|---|
| $12.71 to $17.05 | $17.06 to $21.84 | $21.85 to $41.90 | |
| Options outstanding | 1,204 | 863 | 1,106 |
| Weighted-average exercise price of options outstanding | $15.78 | $20.58 | $31.86 |
| Weighted-average remaining contractual life of options outstanding | 8.3 | 4.6 | 5.0 |
| Options exercisable | 273 | 686 | 1,030 |
| Weighted-average exercise price of options exercisable | $14.06 | $20.29 | $32.06 |
The intrinsic value of options outstanding at December 28, 2023 was $435 and the intrinsic value of options exercisable at December 28, 2023 was $350. The intrinsic value of options exercised was $171, $164 and $1,164 during fiscal 2023, fiscal 2022 and fiscal 2021, respectively. As of December 28, 2023, total remaining unearned compensation cost related to stock options was $4,334, which will be amortized to expense over the remaining weighted-average life of 2.4 years.
- Shareholders’ Equity and Share-Based Compensation (continued)
A summary of the Company’s non-vested stock activity and related information follows (shares in thousands):
| Year Ended | ||||||
|---|---|---|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | ||||
| Shares | Weighted-AverageFairValue | Shares | Weighted-AverageFairValue | Shares | Weighted-AverageFairValue | |
| Outstanding at beginning of period | 212 | $21.07 | 357 | $23.32 | 147 | $31.02 |
| Granted | 107 | 15.68 | 100 | 17.63 | 251 | 19.63 |
| Vested | (81) | 23.77 | (242) | 22.95 | (32) | 30.69 |
| Forfeited | — | — | (3) | 22.93 | (9) | 19.77 |
| Outstanding at end of period | 238 | $17.41 | 212 | $21.07 | 357 | $23.32 |
The Company expenses awards of non-vested stock based on the fair value of the Company’s common stock at the date of grant. As of December 28, 2023, total remaining unearned compensation related to non-vested stock was $1,732, which will be amortized over the weighted-average remaining service period of 2.9 years.
- Employee Benefit Plans
The Company has a qualified profit-sharing retirement savings plan (401(k) plan) covering eligible employees. The 401(k) plan provides a matching contribution equal to 100% of the first 3% of compensation and 50% of the next 2% of compensation deposited by an employee into the 401(k) plan. During fiscal 2023, fiscal 2022 and fiscal 2021, the first 2% of the matching contribution was made with the Company’s common stock. Retirement savings plan expense was $2,179, $2,233 and $1,696 for fiscal 2023, fiscal 2022 and fiscal 2021, respectively.
The Company also sponsors unfunded, nonqualified, defined-benefit and deferred compensation plans. The Company’s unfunded, nonqualified retirement plan includes two components. The first component is a defined-benefit plan that applies to certain participants. The second component applies to all other participants and provides an account-based supplemental retirement benefit.
The Company recognizes actuarial losses and prior service costs related to its defined benefit plan in the consolidated balance sheets and recognizes changes in these amounts in the year in which changes occur through comprehensive income.
- Employee Benefit Plans (continued)
The status of the Company’s unfunded nonqualified, defined-benefit and account-based retirement plan based on the respective December 28, 2023 and December 29, 2022 measurement dates is as follows:
| December 28,2023 | December 29,2022 | |
|---|---|---|
| Change in benefit obligation: | ||
| Benefit obligation at beginning of period | $36,324 | $46,827 |
| Service cost | 487 | 1,055 |
| Interest cost | 1,811 | 1,341 |
| Actuarial gain | (656) | (11,368) |
| Benefits paid | (1,617) | (1,531) |
| Benefit obligation at end of year | $36,349 | $36,324 |
| Amounts recognized in the statement of financial position consist of: | ||
| Current accrued benefit liability (included in Other accrued liabilities) | $(2,060) | $(1,890) |
| Noncurrent accrued benefit liability (included in Other long-term obligations) | (34,289) | (34,434) |
| Total | $(36,349) | $(36,324) |
| Amounts recognized in accumulated other comprehensive loss consist of: | ||
| Net actuarial loss | $2,004 | $2,660 |
| Prior service credit | (196) | (260) |
| Total | $1,808 | $2,400 |
| Year Ended | |||
|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | |
| Net periodic pension cost: | |||
| Service cost | $487 | $1,055 | $1,122 |
| Interest cost | 1,811 | 1,341 | 1,201 |
| Net amortization of prior service cost and actuarial loss | (64) | 1,028 | 1,311 |
| $2,234 | $3,424 | $3,634 | |
The $1,336 loss, net of tax, included in accumulated other comprehensive loss at December 28, 2023, consists of the $1,481 net actuarial loss, net of tax, and the $145 unrecognized prior service credit, net of tax, which have not yet been recognized in the net periodic benefit cost. The $1,774 loss, net of tax, included in accumulated other comprehensive loss at December 29, 2022, consists of the $1,966 net actuarial loss, net of tax, and the $192 unrecognized prior service credit, net of tax, which have not yet been recognized in the net periodic benefit cost.
- Employee Benefit Plans (continued)
The accumulated benefit obligation was $34,788 and $33,719 as of December 28, 2023 and December 29, 2022, respectively.
The pre-tax change in the benefit obligation recognized in other comprehensive loss was as follows:
| Year Ended | ||
|---|---|---|
| December 28, 2023 | December 29, 2022 | |
| Net actuarial gain | $(656) | (11,368) |
| Amortization of the net actuarial loss | — | (1,092) |
| Amortization of the prior year service credit | 64 | 63 |
| Total | $(592) | (12,397) |
The weighted-average assumptions used to determine the benefit obligations as of the measurement dates were as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Discount rate | 5.00% | 5.05% |
| Rate of compensation increase | 4.00% | 4.00% |
The weighted-average assumptions used to determine net periodic benefit cost were as follows:
| Year Ended | |||
|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | |
| Discount rate | 5.05% | 2.85% | 2.45% |
| Rate of compensation increase | 4.00% | 4.00% | 4.00% |
Benefit payments expected to be paid subsequent to December 28, 2023, are as follows:
| Fiscal Year | |
|---|---|
| 2024 | $2,111 |
| 2025 | 2,200 |
| 2026 | 2,314 |
| 2027 | 2,313 |
| 2028 | 2,563 |
| Years 2029 – 2033 | 15,685 |
- Income Taxes
The components of the net deferred tax liability are as follows:
| December 28, 2023 | December 29, 2022 | |
|---|---|---|
| Deferred tax assets | ||
| Accrued employee benefits | $13,653 | $14,133 |
| Operating lease liabilities | 50,601 | 54,767 |
| Gift card liabilities | 6,490 | 6,575 |
| Net operating loss, disallowed interest & tax credit carryforwards | 21,069 | 28,273 |
| Other | 2,378 | 3,791 |
| Total | 94,191 | 107,539 |
| Less valuation allowance | (11,338) | (12,371) |
| Deferred tax assets | 82,853 | 95,168 |
| Deferred tax liabilities | ||
| Depreciation and amortization | (68,164) | (70,849) |
| Operating lease assets | (46,924) | (50,886) |
| Deferred tax liabilities | (115,088) | (121,735) |
| Net deferred tax liability | $(32,235) | $(26,567) |
| Amounts recognized in the consolidated balance sheets consist of: | ||
| Deferred income taxes - other assets | $— | $— |
| Deferred income taxes - liabilities | (32,235) | (26,567) |
| Net amount recognized | $(32,235) | $(26,567) |
As of December 29, 2022, the Company had a federal net operating loss carryforward of $19,656, which was fully utilized during fiscal 2023. As of December 28, 2023 and December 29, 2022 the Company had federal tax credit carryforwards of $4,150 and $4,538, respectively.
As of December 28, 2023 and December 29, 2022, the Company has state net operating loss carryforwards of $209,866 and $238,682, respectively, which will expire primarily in the next 12 to 20 years. As of December 29, 2022, the valuation allowance for a portion of the Company’s state net operating loss carryforwards that are not more likely than not to be realized was $12,371. In fiscal 2023, the Company decreased the valuation allowance by $1,033 to $11,338. The amount of the state net operating loss carryforwards considered realizable could be adjusted if, among other factors, estimates of future taxable income during the carryforward periods are reduced or increased.
- Income Taxes (continued)
Income tax expense (benefit) consists of the following:
| Year Ended | |||
|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | |
| Current: | |||
| Federal | $603 | $(452) | $13 |
| State | 692 | 556 | 129 |
| Deferred: | |||
| Federal | 3,900 | (3,222) | (12,629) |
| State | 1,661 | 10,255 | (3,214) |
| $6,856 | $7,137 | $(15,701) | |
The Company’s effective income tax rate, adjusted for earnings from noncontrolling interests, was 31.7%, (147.6)% and 26.6% for fiscal 2023, fiscal 2022 and fiscal 2021, respectively. The Company's effective income tax rate during fiscal 2022 was negatively impacted by a $9,956 increase in the valuation allowance for state net operating loss carryforwards, partially offset by a corresponding increase in the federal benefit on the valuation allowance of $2,598. Excluding the negative impact of the valuation allowance adjustment, the Company’s effect income tax rate during fiscal 2022 was 4.6%. The Company has not included the income tax expense related to the net earnings attributable to noncontrolling interests in its income tax expense as the entity is considered a pass-through entity and, as such, the income tax expense is attributable to its owners.
A reconciliation of the statutory federal tax rate to the effective tax rate on earnings attributable to The Marcus Corporation follows:
| Year Ended | |||
|---|---|---|---|
| December 28, 2023 | December 29, 2022 | December 30, 2021 | |
| Statutory federal tax rate | 21.0% | 21.0% | 21.0% |
| State income taxes, net of federal income tax benefit | 11.4 | 4.3 | 6.7 |
| Tax credits, net of federal income tax benefit | (5.6) | 22.9 | 1.6 |
| Valuation allowance | (4.8) | (205.9) | (4.1) |
| Federal income tax benefit on state valuation allowance | 1.0 | 53.7 | — |
| Excess tax benefits on share-based compensation | 2.8 | (22.1) | (0.6) |
| Other compensation and benefits | 5.4 | (15.6) | (0.7) |
| Meals and entertainment | 1.1 | (4.1) | (0.4) |
| Other | (0.6) | (1.8) | 3.1 |
| 31.7% | (147.6)% | 26.6% | |
Net income taxes paid in fiscal 2023 were $1,776. Net income taxes refunded in fiscal 2022 and fiscal 2021 were $21,935 and $8,316, respectively. Net income taxes refunded in fiscal 2022 and fiscal 2021 included $22,300 and $7,800, respectively, related to federal net operating loss carrybacks to prior years, as allowed under the provisions of the CARES Act.
- Income Taxes (continued)
The Company hadno unrecognized tax benefits as of December 28, 2023, December 29, 2022 and December 30, 2021. The Company hadno accrued interest or penalties at December 28, 2023 or December 29, 2022. The Company classifies interest and penalties relating to income taxes as income tax expense. For the year ended December 28, 2023, $1 of interest expense was recognized in the consolidated statement of earnings (loss), compared to $683 of interest income for the year ended December 29, 2022 and $60 of interest income for the year ended December 30, 2021.
In the fourth quarter of 2021, the Company settled, with no significant change, an examination by the Internal Revenue Service of its fiscal 2019 and 2020 income tax returns. The examination included the previous five fiscal years, to the extent that net operating losses were carried back to those fiscal years under the CARES Act. With certain exceptions, the Company's state income tax returns are no longer subject to examination prior to fiscal 2019. At this time, the Company does not expect the results from any income tax audit or appeal to have a significant impact on the Company's financial statements.
- Commitments and License Rights
Commitments - The Company has commitments for the completion of construction at various properties totaling approximately $23,233 at December 28, 2023.
License Rights – As of December 28, 2023, the Company had license rights to operatetwo hotels using the Hilton trademark andtwo hotels using the Marriott trademark. Under the terms of the licenses, the Company is obligated to pay fees based on defined gross sales.
- Joint Venture Transactions
At December 28, 2023 and December 29, 2022, the Company held investments with aggregate carrying values of $1,718 and $2,067, respectively. Investments at December 28, 2023 and December 29, 2022 includedone joint venture accounted for under the equity method.
In December 2021, the Company formed a joint venture with Searchlight Capital Partners (“Searchlight”) to acquire the Kimpton Hotel Monaco Pittsburgh (“Monaco”), a 248-room upper upscale hotel in downtown Pittsburgh, Pennsylvania. The Company invested $2,427 for a 10% equity interest in the Monaco joint venture and entered into a management agreement for the hotel. The Monaco joint venture entity, as the borrower, financed the acquisition of Monaco with a non-recourse mortgage loan. In connection with this mortgage loan, the Company provided an environmental indemnity and a “bad boy” guaranty that provides that the lender can recover losses from the Company for certain bad acts of the Monaco joint venture, such as but not limited to fraud, intentional misrepresentation, voluntary incurrence of prohibited debt, prohibited transfers of the collateral, and voluntary bankruptcy of the Monaco joint venture. Under the terms of the Monaco joint venture operating agreement, Searchlight has fully indemnified the Company under the “bad boy” guarantees for any losses other than those attributable to the Company’s own bad acts and has indemnified the Company to its proportionate liability under the environmental liability.
- Business Segment Information
The Company evaluates performance and allocates resources based on the operating income (loss) of each segment. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies.
Following is a summary of business segment information for fiscal 2023, fiscal 2022 and fiscal 2021:
| Theatres | Hotels/Resorts | CorporateItems | Total | |
|---|---|---|---|---|
| Revenues | $458,394 | $270,835 | $346 | $729,575 |
| Operating income (loss) | 36,176 | 17,513 | (19,763) | 33,926 |
| Depreciation and amortization | 48,378 | 18,569 | 354 | 67,301 |
| Assets | 696,128 | 280,568 | 88,407 | 1,065,103 |
| Capital expenditures and acquisitions | 15,131 | 22,890 | 753 | 38,774 |
| Revenues | $407,741 | $269,286 | $367 | $677,394 |
| Operating income (loss) | 8,108 | 18,699 | (18,501) | 8,306 |
| Depreciation and amortization | 47,560 | 19,160 | 353 | 67,073 |
| Assets | 750,941 | 277,990 | 35,667 | 1,064,598 |
| Capital expenditures and acquisitions | 12,087 | 24,515 | 241 | 36,843 |
| Revenues | $271,248 | $186,638 | $358 | $458,244 |
| Operating loss | (27,559) | 5,865 | (19,758) | (41,452) |
| Depreciation and amortization | 51,654 | 20,192 | 281 | 72,127 |
| Assets | 820,547 | 305,928 | 61,886 | 1,188,361 |
| Capital expenditures and acquisitions | 10,299 | 6,783 | — | 17,082 |
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. Corporate assets primarily include cash and cash equivalents, furniture, fixtures and equipment, investments and land held for development.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.